Hagerty director Robert Kauffman sells $191,963 in stock

Published 24/03/2025, 21:36
Hagerty director Robert Kauffman sells $191,963 in stock

Robert Kauffman, a director at Hagerty , Inc. (NYSE:HGTY), a $3.1 billion market cap company with a "GOOD" InvestingPro Financial Health score, has reported the sale of 20,888 shares of Class A Common Stock, according to a recent SEC filing. The transactions, executed on March 21 and March 24, 2025, were part of a prearranged trading plan under Rule 10b5-1. The shares were sold at prices ranging from $9.14 to $9.24, totaling approximately $191,963. Following these sales, Kauffman holds 4,147,676 shares indirectly through Aldel LLC. The stock, currently trading at $9.37, shows technical signs of being oversold, according to InvestingPro analysis, which offers 8 additional key insights about HGTY’s valuation and growth prospects.

In other recent news, Hagerty Inc. reported its financial results for the fourth quarter of 2024, surpassing earnings expectations with an earnings per share (EPS) of $0.02, doubling the forecasted $0.01. The company also exceeded revenue projections, bringing in $292 million compared to the anticipated $279.53 million, marking a 19% year-over-year increase. Despite these positive financial results, the company’s stock experienced a decline in pre-market trading. Hagerty’s strategic initiatives, including significant investments in technology and market expansion, have been highlighted as key drivers of its strong financial performance. The company reported a six-fold increase in operating income, reaching $66 million, and a 178% rise in net income, totaling $78 million for the year. Analysts from Citizens JMP and Truist have shown interest in the company’s cross-selling strategies and the potential impacts of tariffs on operational costs. Hagerty’s leadership has emphasized the importance of its technology investments for future growth, with plans to continue expanding its specialty insurance offerings and marketplace business. The company’s outlook for 2025 includes projected growth in written premiums and total revenue, along with expectations for significant net income gains.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.